Newsletter | October 22, 2026

10.22.26 -- How Cellular Model Solutions Are Transforming Drug Development

Advancing The Human Liver-Chip Toward FDA Qualification

Explore how human-relevant liver models can improve DILI risk assessment and support stronger development decisions while advancing regulatory qualification.

Request Information

Emulate

Overcome Complex Protein Challenges With Optimized Expression

Realizing the potential of next-generation molecules calls on appropriate expression technologies and development processes that can facilitate their path to market.

Request Information

Lonza

Clean Blood And Tissue DNA Kit

Replace centrifugation and tube transfers with a magnetic bead-based workflow for genomic DNA extraction. Four straightforward steps deliver high-purity gDNA for downstream applications.

Request Information

INTEGRA Biosciences

Strategies To Overcome Delays In The Development Of Genomic Medicines

Gain insight into how optimizing LNPs can help overcome drug-delivery challenges, unlocking potential new genomic medicines in a shorter time.

Request Information

Cytiva